Search filters

List of works by Ester Aso

Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment

scientific article published on 04 January 2019

Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety

scientific article published on 15 June 2011

Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease

scientific article published on 13 January 2012

Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration

scientific article

An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.

scientific article

Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

scientific article published on 20 February 2014

Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotine

scientific article published on 02 June 2014

CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 mice.

scientific article published in January 2012

CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.

scientific article published on 18 October 2007

CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

scientific article

CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice.

scientific article published in January 2013

Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model

scientific article published on 05 June 2020

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.

scientific article published on 6 February 2016

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

scientific article published on 17 August 2018

Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.

scientific article published on 05 March 2014

Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice

scientific article published in January 2015

Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease.

scientific article published in January 2012

Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex

scientific article published in January 2011

Complex Inflammation mRNA-Related Response in ALS Is Region Dependent

scientific article

DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease.

scientific article published on 11 September 2013

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

scientific article published on 10 August 2016

Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice

scientific article published in November 2004

Effect of poly(propylene imine) glycodendrimers on beta-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease

scientific article published on 26 September 2013

Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesis

scientific article published on 15 July 2019

Essential role of the N-terminal region of TFII-I in viability and behavior

scientific article

Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease.

scientific article published in October 2012

FOXP2 Expression in Frontotemporal Lobar Degeneration-Tau.

scientific article

Fibrinogen-Derived γ377-395 Peptide Improves Cognitive Performance and Reduces Amyloid-β Deposition, without Altering Inflammation, in AβPP/PS1 Mice.

scientific article

Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype.

scientific article

Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model

scientific article published on 07 August 2018

Genetically modified mice as tools to understand the neurobiological substrates of depression

scientific article published on January 2014

Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis

scientific article published on 13 October 2017

Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice

scientific article published in September 2005

It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)

scientific article published on 14 May 2013

Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology.

scientific article published on 24 January 2017

Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes

scientific article published in January 2015

Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau

scientific article published on 10 September 2015

Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species

scientific article published in April 2015

Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.

scientific article published in January 2011

Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies

scientific article published on 16 July 2015

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies

scientific article published on 20 September 2018

Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection

scientific article from 2019

Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease

scientific article

Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression.

scientific article published on 28 October 2010

The cannabis paradox: when age matters

scientific article published in June 2017

Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease.

scientific article

Paulina is supported by:

About Paulina

Help